Skip to main content
. 2015 Oct 12;6(38):40896–40906. doi: 10.18632/oncotarget.5683

Figure 3.

Figure 3

A. The Kaplan–Meier estimates for overall survival indicated that the group of GBM patients with wt IDH who were randomly assigned to the RT plus TMZ treatment groups exhibited significantly longer survival than did the group who were randomly assigned to RT only. B. Among GBM patients with IDH mutation, a more favorable survival benefit was not observed in the RT plus TMZ treatment group compared to the RT alone group.